OpenURL Connection Search

Select item for more details and to access through your institution.

Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT.
Published in:
2022
By:
- Putcha, Nirupama;
- Anzueto, Antonio R.;
- Calverley, Peter M. A.;
- Celli, Bartolomé R.;
- Tashkin, Donald P.;
- Metzdorf, Norbert;
- Mueller, Achim;
- Wise, Robert A.
Publication type:
journal article
Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.
Published in:
International Journal of COPD, 2018, v. 13, p. 1297, doi. 10.2147/COPD.S153631
By:
- Calverley, Peter MA;
- Anzueto, Antonio R;
- Dusser, Daniel;
- Mueller, Achim;
- Metzdorf, Norbert;
- Wise, Robert A
Publication type:
Article
Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial.
Published in:
International Journal of COPD, 2018, v. 13, p. 605, doi. 10.2147/COPD.S148393
By:
- Wise, Robert A;
- Calverley, Peter MA;
- Carter, Kerstine;
- Clerisme-Beaty, Emmanuelle;
- Metzdorf, Norbert;
- Anzueto, Antonio
Publication type:
Article
Impact and prevention of severe exacerbations of COPD: a review of the evidence.
Published in:
International Journal of COPD, 2017, v. 12, p. 2891, doi. 10.2147/COPD.S139470
By:
- Halpin, David M. G.;
- Miravitlles, Marc;
- Metzdorf, Norbert;
- Celli, Bartolomé
Publication type:
Article
Determinants of exacerbation risk in patients with COPD in the TIOSPIR study.
Published in:
International Journal of COPD, 2017, v. 12, p. 3391, doi. 10.2147/COPD.S145814
By:
- Calverley, Peter M. A.;
- Tetzlaff, Kay;
- Dusser, Daniel;
- Wise, Robert A.;
- Mueller, Achim;
- Metzdorf, Norbert;
- Anzueto, Antonio
Publication type:
Article
Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease.
Published in:
International Journal of COPD, 2015, p. 549, doi. 10.2147/COPD.S71913
By:
- Miravitlles, Marc;
- Price, David;
- Rabe, Klaus F.;
- Schmidt, Hendrik;
- Metzdorf, Norbert;
- Celli, Bartolome
Publication type:
Article
Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease.
Published in:
International Journal of COPD, 2015, v. 10, p. 549, doi. 10.2147/COPD.S71913
By:
- Miravitlles, Marc;
- Price, David;
- Rabe, Klaus F.;
- Schmidt, Hendrik;
- Metzdorf, Norbert;
- Celli, Bartolome
Publication type:
Article
Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial.
Published in:
BMC Pulmonary Medicine, 2014, v. 14, n. 1, p. 163, doi. 10.1186/1471-2466-14-163
By:
- Goossens, Lucas M. A.;
- Inge Leimer;
- Norbert Metzdorf;
- Karin Becker;
- Rutten-van Mölken, Maureen P. M. H.
Publication type:
Article
Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial.
Published in:
2014
By:
- Goossens, Lucas M A;
- Leimer, Inge;
- Metzdorf, Norbert;
- Becker, Karin;
- Rutten-van Mölken, Maureen P M H
Publication type:
journal article
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.
Published in:
2020
By:
- Singh, Dave;
- Bafadhel, Mona;
- Brightling, Christopher E.;
- Sciurba, Frank C.;
- Curtis, Jeffrey L.;
- Martinez, Fernando J.;
- Pasquale, Cara B.;
- Merrill, Debora D.;
- Metzdorf, Norbert;
- Petruzzelli, Stefano;
- Tal-Singer, Ruth;
- Compton, Christopher;
- Rennard, Stephen;
- Martin, Ubaldo J.;
- COPD Foundation Eosinophil Working Group
Publication type:
journal article
Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.
Published in:
2020
By:
- Müllerová, Hana;
- Dransfield, Mark T.;
- Thomashow, Byron;
- Jones, Paul W.;
- Rennard, Stephen;
- Karlsson, Niklas;
- Fageras, Malin;
- Metzdorf, Norbert;
- Petruzzelli, Stefano;
- Rommes, Jean;
- Sciurba, Frank C.;
- Tabberer, Maggie;
- Merrill, Debora;
- Tal-Singer, Ruth
Publication type:
journal article
Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial.
Published in:
2016
By:
- Celli, Bartolomé R.;
- Decramer, Marc;
- Dacheng Liu;
- Metzdorf, Norbert;
- Asijee, Guus M.;
- Tashkin, Donald P.;
- Liu, Dacheng
Publication type:
journal article
Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD.
Published in:
2016
By:
- Calverley, Peter M. A.;
- Rennard, Stephen I.;
- Clerisme-Beaty, Emmanuelle;
- Metzdorf, Norbert;
- Zubek, Valentina Bayer;
- ZuWallack, Richard
Publication type:
journal article
The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.
Published in:
2015
By:
- Anzueto, Antonio;
- Wise, Robert;
- Calverley, Peter;
- Dusser, Daniel;
- Wenbo Tang;
- Metzdorf, Norbert;
- Dahl, Ronald;
- Tang, Wenbo
Publication type:
journal article
Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.
Published in:
Respiratory Research, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12931-015-0216-4
By:
- Tashkin, Donald P.;
- Leimer, Inge;
- Metzdorf, Norbert;
- Decramer, Marc
Publication type:
Article
Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.
Published in:
2015
By:
- Tashkin, Donald P;
- Leimer, Inge;
- Metzdorf, Norbert;
- Decramer, Marc
Publication type:
journal article
Tiotropium might improve survival in subjects with COPD at high risk of mortality.
Published in:
Respiratory Research, 2014, v. 15, n. 6, p. 1, doi. 10.1186/1465-9921-15-64
By:
- Burgel, Pierre-Régis;
- Paillasseur, Jean-Louis;
- Dusser, Daniel;
- Roche, Nicolas;
- Liu, Dacheng;
- Liu, Yufeng;
- Furtwaengler, Armin;
- Metzdorf, Norbert;
- Decramer, Marc
Publication type:
Article
Tiotropium might improve survival in subjects with COPD at high risk of mortality.
Published in:
2014
By:
- Burgel, Pierre-Régis;
- Paillasseur, Jean-Louis;
- Dusser, Daniel;
- Roche, Nicolas;
- Liu, Dacheng;
- Liu, Yufeng;
- Furtwaengler, Armin;
- Metzdorf, Norbert;
- Decramer, Marc;
- UPLIFT(R) Study Investigators;
- UPLIFT® Study Investigators
Publication type:
journal article
Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.
Published in:
2018
By:
- Tashkin, Donald P.;
- Miravitlles, Marc;
- Celli, Bartolomé R.;
- Metzdorf, Norbert;
- Mueller, Achim;
- Halpin, David M. G.;
- Anzueto, Antonio
Publication type:
journal article
Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.
Published in:
NPJ Primary Care Respiratory Medicine, 2015, p. 1, doi. 10.1038/npjpcrm.2015.67
By:
- Wise, Robert;
- Calverley, Peter M. A.;
- Dahl, Ronald;
- Dusser, Daniel;
- Metzdorf, Norbert;
- Müller, Achim;
- Fowler, Andy;
- Anzueto, Antonio
Publication type:
Article
TIOtropium Safety and Performance In Respimat® (TIOSPIRTM): Analysis of Asian cohort of COPD patients.
Published in:
Respirology, 2016, v. 21, n. 8, p. 1397, doi. 10.1111/resp.12856
By:
- Zhong, Nanshan;
- Moon, Hwa S.;
- Lee, Kwan H.;
- Mahayiddin, Aziah A.;
- Boonsawat, Watchara;
- Isidro, Marie G.D.;
- Bai, ChunXue;
- Mueller, Achim;
- Metzdorf, Norbert;
- Anzueto, Antonio
Publication type:
Article
The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV1/FVC Ratio in Tiotropium Safety and Performance in Respimat Participants.
Published in:
2018
By:
- Calverley, Peter M. A.;
- Mueller, Achim;
- Fowler, Andrew;
- Metzdorf, Norbert;
- Wise, Robert A.
Publication type:
journal article

Found: 22

Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT.

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial.

Impact and prevention of severe exacerbations of COPD: a review of the evidence.

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study.

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease.

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease.

Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial.

Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial.

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.

Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.

Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial.

Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD.

The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.

Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.

Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.

Tiotropium might improve survival in subjects with COPD at high risk of mortality.

Tiotropium might improve survival in subjects with COPD at high risk of mortality.

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.

Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.

TIOtropium Safety and Performance In Respimat<sup>®</sup> (TIOSPIR<sup>TM</sup>): Analysis of Asian cohort of COPD patients.

The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV<sub>1</sub>/FVC Ratio in Tiotropium Safety and Performance in Respimat Participants.